Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Global WholeHealth Partners Corp (GWHP-OTC) to Announce that the Antibody Test Kits Offered by .
Global WholeHealth Partners Corp.January 20, 2021 GMT
Global’s Antibody Test Can Detect the New CoViD 19 SARS 2 Strain
SAN CLEMENTE, CA, Jan. 20, 2021 (GLOBE NEWSWIRE) via NewMediaWire Charles Strongo, CEO of Global WholeHealth Partners Corp (GWHP-OTC), comments on https://www.cbsnews.com/news/covid-death-toll-united-states-expected-500k-february/ regarding the potential of 500,000 deaths by mid-February, as stated by the incoming director of the Centers for Disease Control. Mr. Strongo states that “the statement about the death toll reaching 500,000 is staggering, and it is our responsibility to be tested and to follow the rules of the CDC. We must keep testing, wearing masks and following the rules of social distancing, as directed by the CDC. We can defeat this virus. We must no
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ECOFIBRE’S ANANDA HEALTH DIVISION and MEDISCA Announce Exclusive Partnership for Global .
EcofibreJanuary 19, 2021 GMT
Georgetown, KY, Jan. 19, 2021 (GLOBE NEWSWIRE) Ecofibre’s Ananda Health Division, the leading provider of CBD to US independent pharmacies is pleased to announce that it has partnered with MEDISCA to be the exclusive pharmaceutical compounding distributor of Ananda Professional products in the United States, Canada and Australia.
David Neu, CEO of Ananda Health states, “We could not be more proud to partner with the global leader in the pharmaceutical compounding industry. MEDISCA has over 30 years of experience in the industry and both of our organizations have core values that are deeply aligned around education, quality and customer care.”
Press release content from Business Wire. The AP news staff was not involved in its creation.
Tyler Technologies to Provide Electronic Filing to the State of Texas Through 2027
January 19, 2021 GMT
PLANO, Texas (BUSINESS WIRE) Jan 19, 2021
Tyler Technologies, Inc. (NYSE: TYL) announced today an agreement valued at $98 million over five years with the Texas Office of Court Administration (OCA) to extend the use of Tyler’s eFileTexas ™ electronic filing solution through August 2027.
ADVERTISEMENT
Tyler’s initial agreement with the Texas OCA is set to expire in August of 2022. The state was required to go back out to bid for its e-filing project and again selected Tyler to bring advanced electronic filing to the state through at least 2027, with an option to extend the terms through 2032. The eFileTexas solution will continue to serve all of Texas’ 254 counties for both criminal and non-criminal case types.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
January 20, 2021 GMT
TORONTO, ON / ACCESSWIRE / January 20, 2021 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that Urology Associates P.C. (“UA”) has received site Institutional Review Board (“IRB”) approval to commence a pivotal phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) Clinical Study to enroll and treat patients with Bacillus Calmette Guerin(“BCG”)-Unresponsive Carcinoma In-Situ (“CIS”) or are intolerant to BCG Therapy (“Study II”).